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Abstract: This study compared the response of a 9-week cycling training on ventilatory efficiency
under two conditions: (i) Combined with respiratory muscle training (RMT) using a new nasal
restriction device (FeelBreathe) (FB group) and (ii) without RMT (Control group). Eighteen healthy
elite cyclists were randomly separated into the FB group (n = 10) or Control group (n = 8). Gas
exchange was measured breath by breath to measure ventilatory efficiency during an incremental test
on a cycloergometer before (Pre) and after (Post) the nine weeks of training. The FB group showed
higher peak power (∆ (95%HDI) (0.82 W/kg (0.49, 1.17)), VO2max (5.27 mL/kg/min (0.69, 10.83))
and VT1 (29.3 W (1.8, 56.7)) compared to Control at PostFINAL. The FB group showed lower values
from Pre to PostPRE in minute ventilation (VE) (−21.0 L/min (−29.7, −11.5)), Breathing frequency
(BF) (−5.1 breaths/min (−9.4, −0.9)), carbon dioxide output (VCO2) (−0.5 L/min (−0.7, −0.2)),
respiratory equivalents for oxygen (EqO2) (−0.8 L/min (−2.4, 0.8)), heart rate (HR) (−5.9 beats/min
(−9.2, −2.5)), respiratory exchange ratio (RER) (−0.1 (−0.1, −0.0) and a higher value in inspiratory
time (Tin) (0.05 s (0.00, 0.10)), expiratory time (Tex) (0.11 s (0.05, 0.17)) and end-tidal partial pressure
of CO2 (PETCO2) (0.3 mmHg (0.1, 0.6)). In conclusion, RMT using FB seems to be a new and
easy alternative ergogenic tool which can be used at the same time as day-to-day training for
performance enhancement.
Keywords: respiratory muscle training; cyclists; cardiopulmonary exercise testing
1. Introduction
Respiratory muscle training (RMT) has been considered as an effective method to im-
prove the inspiratory muscle strength and performance of athletes of endurance sports [1–5].
Indeed, several studies performed specifically with cyclists have shown that RMT causes
physiological adaptations with improvements in the respiratory system, the peak power
developed and the time trial performance, both in elite and amateur cyclists [6–10]. How-
ever, the RMTs performed in these previous studies have been in static position at rest.
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Thus, it has not been possible to address the possible additive effect of RMT and exercise at
the same time in these previous studies.
Functional RMT while cycling has been investigated previously using 3 different
devices: (i) Power Breathe Kinetic KH1 [11]; (ii) Training Mask v2.0 [12]; and (iii) Feel-
Breathe nasal strips [13]. Using the Power Breathe Kinetic KH1 to RMT while performing
stationary cycling increased the electromyography activity in the diaphragm [6]. Despite
these results, it should be noted that participants in this study with Power Breathe per-
formed a “static” exercise and, therefore, not a specific cycling training exercise. The use of
Training Mask v2.0 while performing 6 weeks of high-intensity cycle ergometer training
resulted in improvements in ventilatory threshold, power output at ventilatory thresh-
old, respiratory compensation threshold, and power output at the intensity of respiratory
compensation threshold [12]. However, the training mask should be used only part-time
during the training season as it could cause inadequate hyperventilation and psychological
discomfort [14].
Recently, a new nasal ventilatory flow restriction and filtering device, called Feel-
Breathe (FB), has been designed, developed and patented to increase nasal airflow resis-
tance [15]. A previous study with elite cyclists has shown that FB used for 10 min on cycle
ergometer at 50% of VO2peak causes acute effects in lung ventilation, gas exchange and
heart rate during exercise, with improvements on ventilatory efficiency, which could be
a target of RMT in sport performance. However, the chronic effect of FB combined with
aerobic training in cyclists is unknown [13].
Therefore, the aim of this study was to analyze the additive effect of RMT using FB
while performing a specific cycling training plan on different cardiorespiratory variables.
We hypothesized, based on the previous results, that the FB group will obtain higher
benefits in terms of ventilatory efficiency and peak power developed compared to exercise
group without FB without changes on VO2 uptake after the period of training.
2. Materials and Methods
2.1. Subjects
Twenty healthy elite cyclists from two sport clubs in Chiclana de la Frontera (Cádiz,
Spain) voluntary participated in this study (mean ± SD, age: 36 ± 10, weight: 71.7 ± 6.7 kg,
height: 1.75 ± 0.06 m). All the cyclists had participated in regional and national champi-
onships during the last 5 years at least. One of them dropped out the training plan due to
illness and another one due to disagreements with the club’s coach, which led to a final
sample of eighteen completing the study.
All of the participants were informed of the aims of the study and requirements during
the first experimental session. In addition, they signed a written informed consent in
accordance with the Declaration of Helsinki. The study protocol and design were approved
by the Ethics Committee University Hospital Puerta del Mar (Date: 22 December 2015).
2.2. Training Program
The training plan of this study was directed and controlled by a national cycling coach
daily. The training intervention lasted 9 weeks, and one group combined the exercise
with RMT at the same time as using the FB device (FB group), and another group trained
without any airflow restriction (CG group). The training was carried out at the Moreno
Periñan velodrome (Chiclana, Cádiz, Spain) and on the road. The distances and slopes of
the roads were controlled for the preparation of the training. Physiological evaluations
were before (Pre) and after (Post) the training program to evaluate breathing efficiency
through gas exchange.
FB was manufactured for the present study in three models, 4, 5 and 6 mm of ventila-
tory flow restriction, which produce different levels of air restriction and inspiratory effort.
FB has been authorized by the Spanish Agency for Medicines and Health Products (AEMPS
No. Exp: 521/15/EC, Spain) (Figure 1). The use of this device during exercise has been
used in previous investigations, both in athletes [13] and in patients with COPD [16,17].
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Figure 1. FeelBreathe (FB) devices of 4, 5 and 6 mm arranged in sheets of 10 units. FB placement mode under the nostrils. 
Participants were randomly assigned to either the cycling training combined with FB 
(FB, n = 10) or control group without FB (Control, n = 8). Both groups were matched by 
age and VO2max. All participants were instructed to avoid changes in their diet or physi-
cal activity while they were following the training plan. The training intensity was set 
based on the heart rate corresponding to the lactate threshold (HRlactate): (i) Regenerative 
(<75% HRlactate); A0 (75–90% HRlactate); A1 (90–95% HRlactate); A2 (95–100% HRlac-
tate); A3 (100–105% HRlactate); A4 (105% HRlactate—HRpeak). Both groups completed a 
volume of 144 h of training during the 9 weeks of intervention, with similar intensity and 
duration adapted to each athlete (Regenerative: ~42/43% of total training time, A0: 
~36/38%, A1: ~8/9%, A2: ~8%, A3: ~3%, A4: ~1%). 
The participants of the FB group were instructed on how to place the FB device cor-
rectly. During the first 2 weeks, all the participants used the 4 mm FB device model, in-
creasing the width of the device to the 5 mm FB model for the next 4 weeks and to 6 mm 
FB during the last 3 weeks of training. 
2.3. Measurements 
At the Andalusian Center for Sports Medicine (Bahía Sur, San Fernando, Spain), pre 
and post training tests were performed on all participants. During the testing day, resting 
tests were done with measurement of weight and height, blood pressure, cardiopulmo-
nary auscultation, baseline spirometry (Cardinal Health Spirometer, D-97204 Hoechberg, 
Germany) and a twelve-lead resting electrocardiogram (Mortara R-SCRIBETM 5, Milwau-
kee, USA). Moreover, maximal inspiratory pressure (MIP) (Micro RPM of Micro Medical, 
Chatham, Kent, UK) was measured according to American Thoracic Society (ATS) proto-
col, choosing the highest value of the 3 efforts with a lower than 5% difference [18]. 
After that, all participants completed an incremental test on a cycle ergometer 
(Cardgirus Bikemarc SL, Barcelona, Spain). This test consisted of a stepwise protocol of 30 
watt increments every minute with constant revolutions per minute of 80–85 rpm, as used 
previously [19,20]. The incremental test continued until exhaustion or until the cadence 
was not maintained. Gas exchange and ventilatory variables were recorded during the 
incremental test using a gas analyzer (Jaeger-CareFusion modelo MasterScreen CPX). The 
oxygen consumption (VO2), carbon dioxide output (VCO2), Breathing frequency (BF), 
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adapted to each athlet (Regenerative: ~42/43% of total training time, A0: ~36/38%, 1:
8/9%, A2: ~8%, A3: ~3%, A4: ~1%).
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increasing the width of the device to the 5 mm FB model for the next 4 eeks a t
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2.3. Measurements
At the Andalusian Center for Sports Medicine (Bahía Sur, San Fernando, Spain),
pre and post training tests were performed on all participants. During the testing day,
resting tests were done with measurement of weight and height, blood pressure, car-
diopulmonary auscultation, baseline spirometry (Cardinal Health Spirometer, D-97204
Hoechberg, Germany) and a twelve-lead resting electrocardiogram (Mortara R-SCRIBETM
5, Milwaukee, USA). Moreover, maximal inspiratory pressure (MIP) (Micro RPM of Micro
Medical, Chatham, Kent, UK) was measured according to American Thoracic Society (ATS)
protocol, choosing the highest value of the 3 efforts with a lower than 5% difference [18].
After that, all participants completed an incremental test on a cycle ergometer (Card-
girus Bikemarc SL, Barcelona, Spain). This test consisted of a stepwise protocol of 30 watt
increments every minute with constant revolutions per minute of 80–85 rpm, as used
previously [19,20]. The incremental test continued until exhaustion or until the cadence
was not maintained. Gas exchange and ventilatory variables were recorded during the
incremental test using a gas analyzer (Jaeger-CareFusion modelo MasterScreen CPX). The
oxygen consumption (VO2), carbon dioxide output (VCO2), Breathing frequency (BF), tidal
volume (Vt), inspiratory tidal volume (VTin), expiratory tidal volume (VTex), inspiratory
time (Tin), expiratory time (Tex), duty cycle (TiTot), minute ventilation (VE), respiratory
equivalents for oxygen (EqO2) and carbon dioxide (EqCO2), end-tidal partial pressure of
O2 (PETO2) and CO2 (PETCO2), and respiratory exchange ratio (RER) were registered in
a breath-by-breath manner and averaged by 10 s. Moreover, two dependent evaluators
Int. J. Environ. Res. Public Health 2021, 18, 777 4 of 13
assessed VT1 from visual inspection of (1) the first disproportionate increase in VE; (2) an
increase in VE/VO2 with no increase in VE/VCO2 (i.e., the ventilatory equivalents); (3)
an increase in PETO2 with no consequent fall in PETCO2, and (4) V-slope plot. VT2 was
determined from visual inspection of (1) the second disproportionate increase in VE, (2)
the first systematic decrease in PETCO2, and (3) the first systematic increase in VE/VCO2.
Rating of Perceived Exertion (RPE) was detected using the Borg Scale CR 0–10 [21].
One minute after the end of exercise, MIP were repeated post-exercise. After the 9-week
training program, all post-tests were performed in the same order and conditions of the
pre-test. The evaluators who performed the tests were blind to which individual they were
evaluating since they did not participate in the training sessions.
3. Statistical Analysis
Values are reported as mean ± standard deviation. For cardiorespiratory variables
analyses, three values were obtained corresponding to three different temporal points in
the incremental test: The maximum value recorded at the pre-training test (Pre), the value
obtained at the post-training test at the same time as the maximum value at the pre-training
test (PostPRE) was obtained, and the maximum value recorded at the post-training test
(PostFINAL) (Figure 2).
Int. J. Environ. Res. Public Health 2021, 18, x 4 of 13 
 
 
tidal volume (Vt), inspiratory tidal volume (VTin), expiratory tidal volume (VTex), inspir-
atory time (Tin), expiratory time (Tex), duty cycle (TiTot), minute ventilation (VE), respir-
atory equivalents for oxygen (EqO2) and carbon dioxide (EqCO2), end-tidal partial pres-
sure of O2 (PETO2) and CO2 (PETCO2), and respiratory exchange ratio (RER) were regis-
tered in a breath-by-breath manner and averaged by 10 s. Moreover, two dependent eval-
uators assessed VT1 from visual inspection of (1) the first disproportionate increase in VE; 
(2) an increase in VE/VO2 with no increase in VE/VCO2 (i.e., the ventilatory equivalents); 
(3) an increase in PETO2 with no consequent fall in PETCO2, and (4) V-slope plot. VT2 was 
determined from visual inspe tion of (1) the second disproportionate increase in VE, (2) 
the first systematic decrease in PETCO2, and (3) the first systematic increas  in VE/ CO2. 
Rating of Perceived Exertion (RPE) was detected using the Borg Scale CR 0–10 [21]. 
One minute after the end of exercise, MIP were repeated post-exercise. After the 9-week 
training program, all post-tests were performed in the same order and conditions of the 
pre-test. The evaluators who performed the tests were blind to which individual they were 
evaluating since they did not participate in the training sessions. 
3. Statistical Analysis 
Values are reported as mean ± standard deviation. For cardiorespiratory variables 
analyses, three values were obtained corresponding to three different temporal points in 
the incremental test: The maximum value recorded at the pre-training test (Pre), the value 
obtained at the post-training test at the same time as the maximum value at the pre-train-
ing test (PostPRE) was obtained, and the maximum value recorded at the post-training test 
(PostFINAL) (Figure 2). 
 
Figure 2. Graphical representation of temporal points selected for statistical analyses. 
Within- and between-group differences were assessed using a Bayesian hierarchical 
regression model. All hyperparameters in the model followed a weakly informative prior 
distribution (i.e., a prior distribution that encoded enough information to restrict the plau-
sible range of values of the parameter space but still left a wide range of values to be cov-
ered) [22]. Inference was performed based on the 95% highest density interval (95%HDI), 
which contains a range of values where we can be 95% certain that the true value lies 
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Within- and between-group differences were assessed using a Bayesian hierarchical
regression model. All hyperparameters in the model followed a weakly informative prior
distribution (i.e., a prior distribution that encoded enough information to restrict the
plausible range of values of the parameter space but still left a wide range of values to
be covered) [22]. Inference was performed based on the 95% highest density interval
(95%HDI), which contains a range of values where we can be 95% certain that the true
value lies given the data at hand and the model fitted. The null value in our analysis is
0, so if this number is not inside the 95%HDI then we can reject that value for practical
purposes [23]. Bayesian estimation of the parameters was obtained by using the package
brms for the R programming language [24]. All parameters estimated showed a good
convergence with values of R̂ = 1 and number of effective sample size > 1000. Further
details about the analysis can be found in the supplemental file S1, while the code and the
dataset to replicate it are stored in https://github.com/JorgeDelro/cyclists_PE.
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4. Results
No significant differences were found between FB and CG groups at the baseline
(Table 1).
Table 1. Participant’s baseline characteristics by group.
Variable FB (n = 10) CG (n = 8) FB vs. CG
Age (years) 35.3 ± 9.4 38.1 ± 11.7 −1.4 (−6.2, 3.9)
Weight (kg) 71.2 ± 4.0 72.2 ± 9.4 −0.5 (−3.7, 2.9)
Height (cm) 176.8 ± 7.1 172.5 ± 4.9 2.0 (−1.1, 5.0)
BMI (kg/m2) 22.7 ± 2.0 24.3 ± 2.9 −0.7 (−1.8, 0.6)
VO2max
(mL/kg/min) 55.8 ± 4.7 51.1 ± 5.4 2.3 (−0.2, 4.6)
MIP (cmH2O) 155.5 ± 36.2 167.6 ± 51.7 −5.4 (−27.7, 14.8)
FB, Feelbreathe group; CG, control group. Values are expressed as mean ± standard deviation. Differences are
expressed as mean (95% HDI).
Regarding within-group differences, the FB group (Table 2) obtained a lower value from Pre
to PostPRE in VE (∆ (95%HDI) =−21.0 L/min (−29.7,−11.5)), BF (−5.1 breaths/min (−9.4, −0.9)),
VCO2 (−0.5 L/min (−0.7,−0.2)), EqO2 (−0.8 L/min (−2.4, 0.8)), HR (−5.9 beats/min (−9.2, −2.5))
and RER (−0.1 (−0.1, −0.0) and a higher value in Tin (0.05 s (0.00, 0.10)), Tex (0.11 s (0.05, 0.17))
and PETCO2 (0.3 mmHg (0.1, 0.6)). Additionally, the FB group (Table 2) increased the peak power
from Pre to PostFINAL (0.7 W/kg (0.5, 0.9)), VT1 (21.0 W (9.6, 32.4)) and VT2 (17.7 W (0.7, 36.2)).
The Control group (Table 3) reached a lower value from Pre to PostPRE in VCO2 (−0.2 L/min
(−0.5, −0.0)) and HR (−4.6 beats/min (−7.7, −1.1)) and a higher value in VT2 (21.0 W (9.6, 32.4)).
Between-group differences for breathing conditions (Table 4) showed a difference in
VT2 (7.69 mL/kg/min (1.86, 13.27)) at Pre; in BF (−10.73 breath/min (−19.7, −2.13)), tin
(0.10 s (−0.00, −0.20)), tex (0.19 s (0.09, 0.30)) and PETCO2 (0.56 mmHg (0.15, 0.97)) at
PostPRE; in Peak power (0.82 W/kg (0.49, 1.17)), VO2max (5.27 mL(kg/min (0.69, 10.83))
and VT1 (29.3 W (1.8, 56.7)) at PostFINAL; in VCO2 (−371.7 L/min (−732.9, −10.2)), tex
(0.14 s (0.01, 0.27)), titot (−2.49% (−4.10, −0.85)) and PETO2 (−0.51 mmHg (−0.99, −0.03))
of ∆ at PostPRE; in Peak power (0.58 W/kg (0.23, 0.92)) and HR (5.0 beats/min (3.5, 9.6)) of
∆ at PostFINAL.
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Table 2. Average of the maximum value obtained by the Feelbreathe group (FB) in each variable at the pre-training test (Pre-Value), value obtained in the post-training test at the same
moment that the maximum in the pre-training test was obtained (PostPRE-Value), and maximum obtained at the post-training test (PostFINAL-Value). Percentage of change (%Change),
increment (∆), and 95% HDI are reported from Pre to PostPRE and from Pre to PostFINAL.
FB (n = 10)
Pre PostPRE PostFINAL
Variable Value Value %Change ∆ (95%CrI) Value %Change ∆ (95%CrI)
Power (W/kg) 4.9 ± 0.3 5.0 ± 0.4 3.3 0.2 (−0.1, 0.4) 5.6 ± 0.4 14.3 0.7 (0.5, 0.9)
VO2max (mL/min) 3981.4 ± 475.8 3714.2 ± 425.2 −6.7 −205.0(−416.0, 16.7) 3988.3 ± 479.6 0.2 11.1 (−217.0, 225.0)
VO2max
(mL/kg/min) 55.8 ± 4.7 53.2 ± 5.8 −4.7 −2.5 (−6.1, 1.6) 56.8 ± 6.6 1.8 0.8 (−3.3, 4.7)
VT1 (W) 159.0 ± 28.5 180.0 ± 33.9 13.2 21.0 (9.6, 32.4)
VT1 (mL/kg/min) 26.7 ± 3.9 29.6 ± 5.7 10.8 2.9 (0.5, 5.4)
VT1 (L/min) 1.9 ± 0.4 2.1 ± 0.5 10.5 0.2 (0.0, 0.4)
VT2 (W) 288.0 ± 28.1 306.0 ± 30.2 6.3 17.7 (0.6, 36.2)
VT2 (mL/kg/min) 47.1 ± 8.7 46.7 ± 8.0 −0.8 −0.4 (−0.4, 3.8)
VT2 (L/min) 3.4 ± 0.4 3.3 ± 0.6 −0.9 −0.0 (−0.3, 0.3)
VE (L/min) 149.1 ± 24.0 126.6 ± 21.4 −15.1 −21.0 (−29.7,−11.5) 152.0 ± 15.7 1.9 3.6 (−12.5, 18.8)
BF (breaths/min) 49.4 ± 10.5 43.4 ± 10.0 −12.1 −5.1 (−9.4, −0.9) 51.5 ± 7.2 4.3 2.9 (−3.6, 9.7)
VCO2 (L/min) 5.2 ± 0.5 4.5 ± 0.3 −13.5 −0.5 (−0.7, −0.2) 4.9 ± 0.3 −5.8 −0.2 (−0.4, 0.1)
EqO2 (L/min) 36.2 ± 4.4 33.1 ± 6.3 −8.6 −3.4 (−5.8, −0.7) 37.9 ± 4.9 4.7 0.8 (−2.3, 3.7)
EqCO2 (L/min) 27.7 ± 2.4 26.9 ± 3.2 −2.9 −0.8 (−2.4, 0.8) 29.7 ± 3.2 7.2 2.1 (−0.3, 4.4)
HR (beats/min) 181.2 ± 8.9 174.9 ± 9.8 −3.5 −5.9 (−9.2, −2.5) 183.3 ± 7.1 1.2 2.0 (−1.0, 5.2)
VTin (L) 3.1 ± 0.3 2.7 ± 1.0 −12.9 −1.2 (−0.3, 0.1) 3.04 ± 0.25 −1.3 −0.04 (−0.22, 0.16)
VTex (L) 3.1 ± 0.3 2.6 ± 1.0 −16.1 −0.4 (−0.9, 0.1) 2.97 ± 0.20 −2.6 −0.10 (−0.32, 0.14)
Tin (s) 0.61 ± 0.11 0.67 ± 0.14 9.8 0.05 (0.00, 0.10) 0.56 ± 0.08 −8.2 −0.05 (−0.18, 0.03)
Tex (s) 0.64 ± 0.11 0.77 ± 0.15 20.3 0.11 (0.05, 0.17) 0.62 ± 0.11 −3.1 −0.03 (−0.12, 0.05)
TiTot (%) 48.5 ± 1.9 46.4 ± 2.4 −4.3 −2.1 (−3.2, 0.9) 47.7 ± 2.2 −1.6 −0.1 (−0.6, 0.4)
PETO2 (mmHg) 16.0 ± 0.4 15.4 ± 0.7 −3.8 −0.4 (−0.63, −0.15) 15.9 ± 0.2 −0.6 −0.0 (−0.3, 0.2)
PETCO2 (mmHg) 4.8 ± 0.4 5.2 ± 0.5 8.3 0.3 (0.1, 0.6) 4.8 ± 0.5 0.6 0.02 (−0.3, 0.3)
RER 1.31 ± 0.09 1.22 ± 0.13 −6.9 −0.1 (−0.1, −0.0) 1.25 ± 0.10 −4.6 −0.06 (−0.11, −0.01)
95% HDIs that 0 is not inside are expressed in bold.
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Table 3. Average of the maximum value obtained by the control group (CG) in each variable at the pre-training test (Pre-Value), value obtained in the post-training test at the same moment
that the maximum in the pre-training test was obtained (PostPRE-Value), and maximum obtained at the post-training test (PostFINAL-Value). Percentage of change (%Change), increment (∆),
and 95% HDI are reported from Pre to PostPRE and from Pre to PostFINAL.
CG (n = 8)
Pre PostPRE PostFINAL
Variable Value Value %Change ∆ (95%CrI) Value %Change ∆ (95%CrI)
Power (W/kg) 4.6 ± 0.3 4.7 ± 0.3 0.9 0.1 (−0.2, 0.3) 4.8 ± 0.3 3.0 0.1 (−0.1, 0.4)
VO2max (mL/min) 3673.0 ± 451.8 3581.6 ± 508.5 −2.5 −94.5(−326.0, 125.0) 3689.3 ± 491.3 0.4 8.1 (−218.0, 239.0)
VO2max
(mL/kg/min) 51.1 ± 5.4 49.4 ± 3.9 −3.3 −1.6 (−5.6, 2.7) 50.9 ± 4.0 −0.4 −0.1 (−4.6, 4.2)
VT1 (W) 144.4 ± 28.8 150.6 ± 27.8 4.3 6.2 (−7.1, 20.3)
VT1 (mL/kg/min) 23.6 ± 4.8 25.9 ± 3.6 9.8 2.3 (−0.5, 5.2)
VT1 (L/min) 1.7 ± 0.4 1.9 ± 0.4 9.9 0.2 (−0.0, 0.4)
VT2 (W) 253.8 ± 52.7 286.3 ± 38.1 12.8 32.5 (11.4, 53.7)
VT2 (mL/kg/min) 39.1 ± 6.5 44.1 ± 5.4 12.8 5.0 (0.6, 9.4)
VT2 (L/min) 2.8 ± 0.6 3.2 ± 0.6 13.1 0.3 (0.1, 0.7)
VE (L/min) 141.9 ± 17.4 139.6 ± 17.9 −1.6 −1.8 (−11.9, 7.70) 140.5 ± 22.3 −1.0 −1.9 (−19.0, 15.7)
BF (breaths/min) 53.3 ± 8.7 54.8 ± 9.3 2.8 1.6 (−3.3, 6.2) 53.0 ± 7.5 −0.6 0.1 (−7.0, 6.4)
VCO2 (L/min) 4.8 ± 0.7 4.5 ± 0.6 −6.3 −0.2 (−0.5, −0.0) 4.9 ± 0.3 2.1 −0.1 (−0.4, 0.1)
EqO2 (L/min) 37.2 ± 3.9 37.3 ± 2.3 0.2 0.4 (−2.3, 3.2) 36.4 ± 1.9 −2.2 −0.5 (−2.3, 3.7)
EqCO2 (L/min) 28.7 ± 2.8 29.4 ± 1.3 2.4 1.2 (−0.7, 2.8) 29.0 ± 2.8 1.0 0.5 (−2.3, 3.0)
HR (beats/min) 178.4 ± 12.6 173.8 ± 13.5 −2.6 −4.6 (−7.7, −1.1) 175.4 ± 14.8 −1.7 −3.0 (−6.4, 0.4)
VTin (L) 2.74 ± 0.57 2.69 ± 0.6 −1.8 −0.03(−0.29, 0.24) 2.75 ± 0.56 0.4 0.01 (−0.20, 0.24)
VTex (L) 2.73 ± 0.60 2.62 ± 0.59 −4.0 −0.1 (−0.7, 0.5) 2.70 ± 0.54 −1.1 −0.02 (−0.27, 0.22)
Tin (s) 0.57 ± 0.11 0.56 ± 0.10 −1.8 −0.01 (−0.06, 0.04) 0.57 ± 0.09 0.5 0.01(−0.07, 0.09)
Tex (s) 0.58 ± 0.10 0.57 ± 0.09 −1.7 −0.01 (−0.08, 0.05) 0.58 ± 0.06 0.5 −0.01 (−0.09, 0.08)
TiTot (%) 49.3 ± 2.0 49.6 ± 1.6 0.6 0.4 (−0.8, 1.5) 49.9 ± 2.2 1.2 −0.0 (−0.3, 0.3)
Vt/Ti (L/s) 4.81 ± 0.56 4.70 ± 0.64 −2.3 −0.1 (−0.3, 0.2) 4.72 ± 0.82 −1.9 −0.1 (−0.6, 0.4)
Vt (L) 2.74 ± 0.61 2.62 ± 0.60 −4.4 −0.1 (−0.3, 0.1) 2.69 ± 0.54 −1.8 −0.0 (−0.3, 0.2)
PETO2 (mmHg) 16.1 ± 0.3 16.1 ± 0.3 −0.1 −0.1 (−0.31, 0.1) 16.0 ± 0.2 −0.6 −0.1 (−0.3, 0.1)
PETCO2 (mmHg) 4.7 ± 0.4 4.6 ± 0.1 −2.1 0.1 (−0.2, 0.3) 4.8 ± 0.5 2.2 0.02 (−0.21, 0.26)
RER 1.30 ± 0.05 1.27 ± 0.10 −2.3 −0.0 (−0.1, 0.0) 1.26 ± 0.09 −3.1 −0.04 (−0.09, 0.02)
95% HDIs that 0 is not inside are expressed in bold.
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Table 4. Between-group differences for breathing conditions at the pre-training test (Pre), at the value obtained in the post-training test at the same moment that the maximum in the
pre-training test was obtained (PostPRE), at the maximum value obtained at the post-training test (PostFINAL), and between increments at PostPRE (∆ PostPRE) and PostFINAL (∆ PostFINAL).
Variable
FB vs. Control
Pre PostPRE PostFINAL ∆ PostPRE ∆ PostFINAL
Power (W/kg) 0.26 (−0.09, 0.59) 0.39 (−0.04, 0.76) 0.82 (0.49, 1.17) 0.12 (−0.18, 0.44) 0.58 (0.23, 0.92)
VO2max (mL/min) 285.0 (−131.0, 750.0) 172 (−277.0, 619.0) 280.0 (−157.0, 740.0) −110.6 (−366.0, 152.0) −5.1 (−362.9, 346.8)
VO2max (mL/kg/min) 4.53 (−0.19, 9.45) 4.27 (−1.0, 9.0) 5.27 (0.69, 10.83) −0.39 (−5.12, 4.35) 1.2 (−4.5, 6.9)
VT1 (W) 14.5 (−12.4, 43.0) 29.3 (1.8, 56.7) 14.8 (−3.5, 32.9)
VT1 (mL/kg/min) 2.94 (−1.26, 7.31) 3.58 (−0.68, 7.93) 0.5 (−3.2, 4.3)
VT1 (L/min) 0.20 (−0.18, 0.60) 0.23 (−0.13, 0.63) 0.03 (−0.22, 0.29)
VT2 (W) 32.5 (−5.17, 67.5) 19.4 (−17.5, 54.7) −14.8 (−43.6, 13.9)
VT2 (mL/kg/min) 7.69 (1.86, 13.27) 2.61 (−2.77, 8.43) −5.4 (−11.3, 0.6)
VT2 (L/min) 0.51 (−0.00, 0.98) 0.13 (−0.36, 0.61) 0.2 (−0.8, 0.0)
VE (L/min) 6.68 (−12.25, 26.0) −12.01 (−31.76, 6.1) 11.48 (−7.25, 30.8) −19.77 (−39.95, 0.10) 5.5 (−18.9, 30.2)
BF (breaths/min) −3.90 (−11.9, 4.88) −10.73 (−19.7, −2.13) −1.51 (−10.3, 7.21) −7.20 (−17–41, 3.19) 2.8 (−6.5, 11.3)
VCO2 (L/min) −382.6 (−889, 82.4) −22.1 (−542, 436.0) −287.7 (−772, 223.8) −371.7 (−732.9, −10.2) −0.03 (−0.30, 0.24)
EqO2 (L/min) −1.03 (−4.97, 3.15) −4.36 (−8.41, 0.03) 0.51 (−3.84, 4.55) −3.51 (−8.07, 1.21) 1.3 (−3.2, 5.8)
EqCO2 (L/min) −0.96 (−3.57, 1.44) −2.50 (−4.97, 0.38) 0.65 (−1.87, 3.09) −1.61 (−4.87, 1.81) 1.6 (−1.8, 5.2)
HR (beats/min) 2.80 (−6.91, 13.1) 1.46 (−8.96, 11.3) 7.78 (−2.58, 17.5) −1.08 (−5.47, 3.27) 5.0 (3.5, 9.6)
VTin (mL) 320.7 (−177.0, 858.0) −21.3 (−530.0, 564.0) 4.1 (−536.0, 522.0) −371.0 (−1075.3, 335.0) −0.05 (−0.34, 0.24)
Vtex (mL) 340.3 (−174.0, 880.0) −28.6 (−586.0, 509.0) −9.8 (−543.0, 518.0) −324.0 (−1002.6, 374.1) −0.07 (−0.41, 0.26)
Tin (s) 0.03 (−0.06, 0.13) 0.10 (−0.00, −0.20) −0.01 (−0.11, 0.08) 0.06 (−0.04, 0.17) −0.05 (−0.15, 0.06)
Tex (s) 0.01 (−0.04, 0.16) 0.19 (0.09, 0.30) 0.04 (−0.06, 0.14) 0.14 (0.01, 0.27) −0.02 (−0.14, 0.09)
Titot (%) −0.79 (−2.85, 1.07) −3.19 (−5.25, 1.10) −2.12 (−4.07, 0.02) −2.49 (−4.10, −0.85) −0.1 (−0.5, 0.3)
PETO2 (mmHg) −0.17 (−0.58, 0.27) −0.65 (−1.08, 0.21) −0.06 (−0.46, 0.37) −0.51 (−0.99, −0.03) 0.0 (−0.2, 0.3)
PETCO2 (mmHg) 0.11 (−0.28, 0.50) 0.56 (0.15, 0.97) 0.06 (−0.36, 0.46) 0.48 (−0.02, 0.98) 0.00 (−0.28, 0.30)
RER 0.01 (−0.07, 0.09) −0.05 (−0.14, 0.04) −0.00 (−0.09, 0.09) −0.06 (−0.12, 0.01) −0.02 (−0.09, 0.05)
95% HDIs that 0 is not inside are expressed in bold.
Int. J. Environ. Res. Public Health 2021, 18, 777 9 of 13
Within-group differences were found pre-test and pre-training vs. pre-test and post-
training in MIP for FB (30.5 cmH2O (18.1, 43.0)) and CG (15.4 cmH2O (2.6, 27.7) and in RPE
post-training vs. pre-training for the control group (0.7 (0.1–1.4)) (Table 5).
Table 5. Within-group pre- and post-test differences in MIP and RPE values.
FB (n = 10)
Variable Pre-Incremental Test Post-Incremental Test %Change
∆ (95% HDI)
Pre vs. Pre ∆POST vs. ∆PRE
MIPPRE (cmH2O) 165.3 ± 35.5 172.4 ± 34.4 4.3 30.5
(18.1, 43.0)
−7.5
(−24.7, 10.2)MIPPOST (cmH2O) 198.2 ± 35.2 200.9 ± 36.7 1.3
Value %Change Post vs. Pre
RPEPRE 8.9 ± 1.0 6.7 0.6 (−0.0 to 1.2)RPEPOST 9.5 ± 0.5
CG (n = 8)
Variable Pre-incremental test Post- incremental test %Change ∆ (95% HDI)
Pre vs. Pre ∆POST vs. ∆PRE
MIPPRE (cmH2O) 180.8 ± 44.0 178.5 ± 54.7 −1.3 15.4
(2.6, 27.7)
3.7
(−14.7, 21.9)MIPPOST (cmH2O) 195.6 ± 37.1 191.6 ± 33.0 −2.1
Value %Change Post vs. Pre
RPEPRE 8.4 ± 0.9 9.5 0.7 (0.1, 1.4)RPEPOST 9.2 ± 0.7
95% HDIs that 0 is not inside are expressed in bold. MIP: maximal inspiratory pressure; RPE: rating of perceived exertion; PRE and POST
subindex indicates pre- and post-training respectively; %Change, percentage of change; Pre vs. Pre, pre-test and pre-training MIP value vs.
pre-test and post-training MIP value; ∆POST vs. ∆PRE, increase in MIP value during incremental test post-training vs. increase in MIP value
during PE test pre-training; Post vs. Pre, post-training RPE value vs. pre-training RPE value.
Finally, no significant between-group differences were found in the increments in MIP
or RPE values (Table 6).
Table 6. Between-group differences in the increments in MIP and RPE values.
Variable
∆ (95% HDI)
Pre vs. Pre ∆POST vs. ∆PRE Post vs. Pre
MIP (cmH2O) 17.0 (−1.6, 35.3) −4.5 (−22.3, 10.7)
RPE −1.1 (−2.4, 0.2)
Differences are expressed as FB vs. CG. MIP: maximal inspiratory pressure; RPE: rating of perceived exertion. Pre
vs. Pre, pre-test and pre-training MIP value vs. pre-test and post-training MIP value; ∆POST vs. ∆PRE, increase in
MIP value during incremental test post-training vs. increase in MIP value during PE test pre-training; Post vs.
Pre, post-training RPE value vs. pre-training RPE value.
5. Discussion
The main finding of the present study was that the ventilatory efficiency and the
breathing pattern were improved after the exercise training program in the FB group
at the maximum intensity reached in the Pre-test (PostPRE) but not in the control group.
FB showed improvements in the time trial and hence in the maximum peak of power
developed in the maximum test but without changes in the VO2max compared to pre-
training values, while the Control group remained unchanged. This could be explained
in part by the higher VO2max and VT1 in the FB compared to the Control group after
the training program at maximum values (PostFINAL). Moreover, VT2 showed similar
values between conditions after intervention despite the Control group beginning with
higher values at Pre. Therefore, only the combination of cyclist training with RMT and
FB optimized the breathing pattern such that it could improve performance. To our
knowledge, this is the first study which has analyzed the benefits on ventilatory efficiency
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and breathing pattern in elite cyclists after 9 weeks of traditional endurance training
combined with respiratory muscle training at the same time as FB is used.
In agreement with our results, RMT has been documented to improve performance in
a wide range of exercise modalities including running, cycling, swimming and rowing [3].
In a study by Holm et al. [7], where 20 trained cyclists and triathletes underwent aerobic
training of the respiratory muscles, a significant improvement (of 4.75%) was observed in
the time trial as well as in the endurance of the respiratory muscles compared to the control
group, but without changes in VO2max. In agreement, McEntire et al. [25], showed that
specific training of respiratory muscles through the use of Power Breathe at 15% of MIP
in cyclists improved physical performance (18% Exercise Group vs. 10% control group),
also without changes in VO2max, RPE or dyspnea. In that sense, our study found that
the FB group improved 14.3% in the time trial after intervention, while the Control group
remained unchanged (~3%) and without any effect on VO2max in both groups.
The observed gain in the time trial performance in these studies, without an increase
in VO2max, may be due to an improvement on ventilatory efficiency. In concordance,
our results showed improvements only in FB group at PostPRE moment with significant
reductions in VE, BF, VCO2, EqO2, Vt/Ti and RER values and with significant increments
in Tin, Tex and PETCO2 values at the same maximum intensity of Pre-moment.
Minute VE was reduced by 13.8% in a moderate intensity exercise in hypoxic condition
after only four weeks of inspiratory muscle training (IMT), which means a reduction of
the physiological demand of exercise [26]. Similar reduction in VE (15%) was observed
only in the FB group in our study at the PostPRE moment. Moreover, it was only in the FB
group that the BF dropped ~12%, which can indicate, together with a longer inspiratory
time (~9.8%), that there has been a correct training of the respiratory muscles, which are
then able to obtain slower and deeper breaths. This, together with a reduction in EQO2
of −8.6% without changes in EQCO2, leads us to a lower dynamic hyperinflation and
greater ventilatory efficiency with a similar oxygen uptake with lower ventilation. This
physiologic phenomenon triggered a lower heart frequency (~3.5%) and RER (~6.6%) at the
same intensity moment, therefore showing an improvement in cardiovascular performance,
lower cardiac output and higher energy efficiency. Moreover, FB causes nasal inspirations
and mouth exhalations during training sessions, improving the humidification, heating
and filtering of the air as it represents a normal mechanism of heat and moisture exchange
in the respiratory tract [27].
All changes on ventilatory parameters in FB group after the intervention lead to the
improvement of both VT1 and VT2 thresholds (~13.2 and 6.3%; respectively), which are
relevant factors for performance and metabolic flexibility during exercise. In fact, a shift
to the right of ventilatory thresholds means a better use of fat as an energy source, saving
energy from muscle glycogen, preventing fatigue and improving the trial time and the peak
of power developed. Despite the fact that the FB group improved the peak of maximum
power after training, the subjective perception of effort remained unchanged. Hence, RMT
with FB combined with aerobic training may improve the efficiency of oxygen delivery,
transport and utilization for fat oxidation during exercise. The group that trained without
FB only improved the VT2, but this could be due in part to the fact that this group begun
the intervention with lower values in Pre-moment compared to the FB group. However,
the magnitude of the Pre-Post change was similar for VT2 between groups, but not for VT1,
where the FB group obtained greater improvements.
Furthermore, one of the most important variables to quantify respiratory performance
is the MIP. Enright el al. [28] showed that, after 8 weeks of IMT, there was a significant
increase in MIP from 142 to 193 cmH2O. In agreement, another study conducted with
cyclists demonstrated that IMT for 10 weeks improved MIP by 34% and test time to
exhaustion [29]. Moreover, Archiza et al. [30] found that 6 weeks of pressure-threshold
IMT improved running time to exhaustion and repeated sprint ability in soccer players. In
our study, the FB group showed a significant increase in MIP of 30.5 cmH2O, while that of
the CG group was only 15.4 cmH2O. However, no significant between-groups differences
Int. J. Environ. Res. Public Health 2021, 18, 777 11 of 13
were found in the increments of MIP. Moreover, the FB group started from a lower average
baseline, which may be responsible for the steeper increase. Nonetheless, the higher effect
found in MIP at Pre vs. Pre and the positive change showed from pre-test to post-test
either pre- and post-training (negative for CG group) make us claim that further studies
are necessary to confirm the ergogenic effect of FB on MIP.
Thus, RMT has been proposed as an ergogenic aid for performance enhancement in
training protocols [3]. In this sense, recent studies have been shown the positive effect of
training the respiratory muscles at the same time as exercise [12] and not doing so in static
situations as is usually done [1,31]. This is, without doubt, one of the biggest advantages
of FB.
6. Conclusions
FB is a new and easy device for respiratory muscle training that can be used during
the practice of physical exercise. It also could be used while performing most daily tasks
unlike other devices for IMT, which have to be used in static position. Moreover, FB is a
valid and useful alternative to the training mask since it could be easier and, especially,
more comfortable. Hence, FB could be incorporated into the training of this type of
athlete as a further stimulus to training with the goal of improving both the specific and
respiratory muscles.
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